- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06048406
Effect of Health Education on Promoting Influenza Vaccination Health Literacy
Effect of Health Education on Promoting Influenza Vaccination Health Literacy Among Primary School Students
The goal of this cluster randomized controlled trial is to evaluate the effect of health education interventions on influenza vaccination rates and health literacy in primary school students in the city of Dongguan in China.
Individuals aged 7 to 12 years who are in grades 4-5 in primary schools in Dongguan will be enrolled. 20 primary schools will be randomly selected, with half designated as intervention group schools and the remaining half as control group schools. The intervention group will receive a monthly health education intervention focused on influenza vaccination for 5 months, while the control group will continue with their routine school health education for 5 months.
Researchers will compare the differences in influenza vaccination rates and influenza vaccination health literacy levels between the intervention and control groups after 5 months to see if health education can promote influenza vaccination health literacy among primary school students.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction: Influenza is a major public health threat, and vaccination is the most effective prevention method. However, vaccination coverage remains suboptimal. Low health literacy regarding influenza vaccination may contribute to vaccine hesitancy. This study aims to evaluate the effect of health education interventions on influenza vaccination rates and health literacy.
Methods and analysis: This cluster randomized controlled trial will enroll 3036 students in grades 4-5 from 20 primary schools in Dongguan City, China. Schools will be randomized to an intervention group receiving influenza vaccination health education or a control group receiving routine health education. The primary outcome is influenza vaccination rate. Secondary outcomes include health literacy levels, influenza diagnosis rate, influenza-like illness incidence, and vaccine protection rate. Data will be collected through questionnaires, influenza surveillance, and self-reports at baseline and study conclusion.
Ethics and dissemination: Ethical approval has been sought from the Ethics Committee of the School of Public Health, Sun Yat-sen University. Findings from the study will be made accessible to both peer-reviewed journals and key stakeholders.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lin Xu, PhD
- Phone Number: 86-20-87335523
- Email: shellylxu@gmail.com
Study Contact Backup
- Name: Chen Jingyi, Master
- Phone Number: +86-13602477650
- Email: jychen0501@163.com
Study Locations
-
-
Guangdong
-
Dongguang, Guangdong, China, 510000
- Recruiting
- Dongguang Center for Disease Control and Prevention
-
Contact:
- Lin Xu, PhD
- Phone Number: +8613602477650
- Email: xulin27@mail.sysu.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primary school students within the age range of 7-12 years.
- Students and their parents who voluntarily agree to participate in the study and provide signed informed consent.
- Permanent residents of Dongguan City who are expected to complete the project without transferring schools during the study period.
Exclusion Criteria:
- Individuals with contraindications to influenza vaccination, who have recently received an influenza vaccination, diagnosed with influenza or confirmed as influenza-like cases at the commencement of the study.
- Unwilling to participate in the project.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
The intervention group will receive a monthly health education intervention focused on influenza vaccination literacy for 5 months.
|
The intervention group will receive a health education intervention focused on influenza vaccination literacy, while the control group will continue with their standard school health education without any additional intervention.
An influenza vaccination health education including topics such as the importance of influenza vaccination, benefits of vaccination, and vaccination methods, will be developed and reviewed by an expert group.
The package for the intervention group will include educational activities, distribution of promotional materials, vaccination services, and distribution of vaccination souvenirs.
|
|
No Intervention: Control
The control group will continue with their routine school health education for 5 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
influenza vaccination rate
Time Frame: Within 20 weeks from enrollment
|
he influenza vaccination rate will be calculated as the number of vaccinated individuals divided by the total number of individuals, multiplied by 100%.
|
Within 20 weeks from enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
influenza incidence
Time Frame: Within 20 weeks from enrollment
|
The influenza incidence will be calculated as the number of individuals diagnosed with influenza divided by the total number of individuals, multiplied by 100%
|
Within 20 weeks from enrollment
|
|
influenza vaccine protection rate
Time Frame: Within 20 weeks from enrollment
|
The influenza vaccine protection rate will be calculated as the difference between the incidence rate in unvaccinated individuals and the incidence rate in vaccinated individuals, divided by the incidence rate in unvaccinated individuals, multiplied by 100%.
|
Within 20 weeks from enrollment
|
|
influenza-like illness incidence
Time Frame: Within 20 weeks from enrollment
|
The ILI incidence will be calculated as the number of ILI cases divided by the total number of participants, multiplied by 100%.
|
Within 20 weeks from enrollment
|
|
influenza vaccination health literacy level
Time Frame: Within 20 weeks from enrollment
|
Regarding the influenza vaccination health literacy level, each correct answer for the health literacy research questionnaire will be scored as one point, with incorrect answers receiving no points.
|
Within 20 weeks from enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lin Xu, PhD, Sun Yat-sen University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SunYat-senU20230908
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Influenza
-
Novartis VaccinesCompletedInfluenza | Seasonal Influenza | Human Influenza | Influenza Due to Unspecified Influenza VirusBelgium
-
Gamaleya Research Institute of Epidemiology and...CompletedInfluenza A | Influenza A Virus Infection | Influenza Epidemic | Influenza H5N1Russian Federation
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza Immunisation | Avian InfluenzaUnited States
-
Canadian Immunization Research NetworkCHU de Quebec-Universite Laval; McGill University Health Centre/Research Institute... and other collaboratorsActive, not recruitingAvian Influenza | H5N1 Virus | H5N1 Influenza | Avian Influenza A VirusCanada
-
Vanderbilt University Medical CenterHuman Vaccines ProjectCompletedVaccine Reaction | Influenza | Influenza, Human | Influenza A | Influenza Type B | Influenza A H3N2 | Influenza A H1N1United States
-
Ab&B Bio-tech Co., Ltd.JSYither Biotech Co., LtdActive, not recruitingInfluenza | Influenza VaccineChina
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza | Avian Influenza | H1N1 InfluenzaUnited States
-
National Institute of Allergy and Infectious Diseases...University of Oxford; Wellcome Trust; World Health OrganizationCompletedInfluenza | Avian Influenza | Severe InfluenzaSingapore, Thailand, Vietnam
-
NPO PetrovaxCompletedVaccine Reaction | Influenza | Influenza, Human | Influenza A | Acute Respiratory Infection | Influenza Type B | Flu | Influenza A H3N2 | Influenza A H1N1 | Flu, Human | Influenza EpidemicRussian Federation
-
National Institute of Allergy and Infectious Diseases...Completed
Clinical Trials on Health education
-
Federal University of PelotasActive, not recruiting
-
Universiti Sains MalaysiaNot yet recruitingKnowledge, Attitudes, Practice | Early Childhood Caries
-
University of PretoriaUnknown
-
Ankara UniversityCompletedEducation | Fertility | YouthTurkey
-
Junyan ZhaoActive, not recruitingTumor Chemotherapy PatientsChina
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiCompletedMotivational Interviewing | Health EducationTurkey (Türkiye)
-
Zhongnan HospitalRecruitingLymphoma | Leukaemia | Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaChina
-
T.C. ORDU ÜNİVERSİTESİNot yet recruitingHealth Education | Cervical Cancers | Peer Support
-
Cardenal Herrera UniversityRecruiting
-
Tianjin HospitalCompletedLumbar Disc HerniationChina